Logo image of ZEN.CA

ZENTEK LTD (ZEN.CA) Stock Fundamental Analysis

TSX-V:ZEN - TSX Venture Exchange - CA98942X1024 - Common Stock - Currency: CAD

2.03  +0.03 (+1.5%)

Fundamental Rating

3

ZEN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Equipment & Supplies industry. While ZEN seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ZEN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ZEN had negative earnings in the past year.
In the past year ZEN has reported a negative cash flow from operations.
In the past 5 years ZEN always reported negative net income.
In the past 5 years ZEN always reported negative operating cash flow.
ZEN.CA Yearly Net Income VS EBIT VS OCF VS FCFZEN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

ZEN has a Return On Assets of -56.02%. This is in the better half of the industry: ZEN outperforms 71.43% of its industry peers.
ZEN has a Return On Equity of -65.80%. This is in the better half of the industry: ZEN outperforms 78.57% of its industry peers.
Industry RankSector Rank
ROA -56.02%
ROE -65.8%
ROIC N/A
ROA(3y)-55.19%
ROA(5y)-53.21%
ROE(3y)-60.58%
ROE(5y)-96.95%
ROIC(3y)N/A
ROIC(5y)N/A
ZEN.CA Yearly ROA, ROE, ROICZEN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

ZEN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZEN.CA Yearly Profit, Operating, Gross MarginsZEN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K

More info and screens

5

2. Health

2.1 Basic Checks

ZEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZEN has more shares outstanding
The number of shares outstanding for ZEN has been increased compared to 5 years ago.
Compared to 1 year ago, ZEN has a worse debt to assets ratio.
ZEN.CA Yearly Shares OutstandingZEN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ZEN.CA Yearly Total Debt VS Total AssetsZEN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 37.41 indicates that ZEN is not in any danger for bankruptcy at the moment.
ZEN has a Altman-Z score of 37.41. This is amongst the best in the industry. ZEN outperforms 100.00% of its industry peers.
ZEN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.01, ZEN belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 37.41
ROIC/WACCN/A
WACC7.72%
ZEN.CA Yearly LT Debt VS Equity VS FCFZEN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.83 indicates that ZEN should not have too much problems paying its short term obligations.
ZEN's Current ratio of 1.83 is fine compared to the rest of the industry. ZEN outperforms 64.29% of its industry peers.
ZEN has a Quick Ratio of 1.48. This is a normal value and indicates that ZEN is financially healthy and should not expect problems in meeting its short term obligations.
ZEN has a better Quick ratio (1.48) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.48
ZEN.CA Yearly Current Assets VS Current LiabilitesZEN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

ZEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.61%, which is quite good.
ZEN shows a strong growth in Revenue. In the last year, the Revenue has grown by 92.56%.
Measured over the past years, ZEN shows a very strong growth in Revenue. The Revenue has been growing by 131.56% on average per year.
EPS 1Y (TTM)12.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.02%
Revenue 1Y (TTM)92.56%
Revenue growth 3Y131.56%
Revenue growth 5YN/A
Sales Q2Q%204.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZEN.CA Yearly Revenue VS EstimatesZEN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M
ZEN.CA Yearly EPS VS EstimatesZEN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2023 2024 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZEN.CA Price Earnings VS Forward Price EarningsZEN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZEN.CA Per share dataZEN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENTEK LTD

TSX-V:ZEN (6/6/2025, 7:00:00 PM)

2.03

+0.03 (+1.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)06-25 2025-06-25/amc
Inst Owners1.66%
Inst Owner ChangeN/A
Ins Owners5.77%
Ins Owner ChangeN/A
Market Cap212.52M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3284.71
P/FCF N/A
P/OCF N/A
P/B 13.12
P/tB 13.12
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.02%
ROE -65.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.19%
ROA(5y)-53.21%
ROE(3y)-60.58%
ROE(5y)-96.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.77%
Cap/Sales 218.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.48
Altman-Z 37.41
F-Score3
WACC7.72%
ROIC/WACCN/A
Cap/Depr(3y)388.68%
Cap/Depr(5y)1741.19%
Cap/Sales(3y)2084.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)92.56%
Revenue growth 3Y131.56%
Revenue growth 5YN/A
Sales Q2Q%204.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.69%
OCF growth 3YN/A
OCF growth 5YN/A